Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Invega in symptomatic schizophrenia
NCT01362439Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of paliperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Started Jan 2009; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01362439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01362439.